. . . . . . . "[Pioglitazone is a peroxisome proliferator-activated receptor gamma (PPAR?) activator used in the treatment of type 2 diabetes (DM2) patients and it has been suggested that can induce bone loss.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:34+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .